Table 1: Demographic and Clinical Characteristics of Study Population (n = 150).
| n | Percent | ||
| Age median | 28 (21, 35) | ||
| Born outside US | 137 | 91% | |
| ALT > 2 × ULN | 6 | 4% | |
| eAg positive | 20 | 13% | |
| Antiviral indicated during pregnancy (HBV DNA > 10^6 IU/ml at 28-32 wks gestation) | 19 | 13% |